Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 11.66
-0.16 (-1.31%)
Oct 20, 2025, 11:52 AM CET
Grifols Market Cap
Grifols has a market cap or net worth of €7.13 billion as of October 20, 2025. Its market cap has increased by 12.73% in one year.
Market Cap
7.13B
Enterprise Value
18.62B
Revenue
7.45B
Ranking
n/a
PE Ratio
26.16
Stock Price
€11.66
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 7.13B, an increase of 877.87%. That is a compound annual growth rate of 12.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 7.13B | 25.48% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | 14.16B | -24.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 3.07B |
| Almirall | 2.60B |
| Faes Farma | 1.39B |
| Pharma Mar | 1.37B |
| Clínica Baviera | 680.43M |
| Oryzon Genomics | 265.74M |
| Atrys Health | 254.18M |
| Laboratorio Reig Jofre | 243.36M |